Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.

Abstract:

:A common form of multidrug resistance in human cancer results from expression of the MDR1 gene which encodes a plasma membrane energy-dependent multidrug efflux pump. We have engineered transgenic mice which express this multidrug transporter in their bone marrow cells and demonstrated that peripheral WBC of these animals provide a rapid and reliable system for assessing the bioactivity of agents that reverse multidrug resistance. Immunocytochemical analysis of bone marrow smears suggests that the activation of the MDR1 transgene has probably occurred at a very early stage of bone marrow differentiation since most bone marrow cells express the transporter. Expression of this transgene in bone marrow produces about 10-fold resistance to leukopenia induced by taxol compared to normal bone marrow. Chemosensitization of MDR1 mice to daunomycin and taxol, measured by a fall in WBC, is detectable at a dose as low as 0.01 mg/kg R-verapamil. A dose of 0.5 mg/kg R-verapamil reduces the WBC by nearly 50%. Chemosensitization of MDR-transgenic mice with 5 mg/kg R-verapamil, which is highly effective in reversing MDR and readily tolerated by mice, necessitates a reduction of the maximum tolerated dose of most chemotherapeutic agents by only 20%. In addition, detailed histopathological examination shows that treatment of mice with chemotherapeutic drugs and R-verapamil does not change the organ-related toxicity pattern but only moderately accentuates inherent toxic side effects of the chemotherapeutic agents. We conclude that MDR1-transgenic mice represent a valid model for evaluating efficacy, potency, and toxicity associated with chemotherapy and chemosensitization of multidrug-resistant cells in animals.

journal_name

Cancer Res

journal_title

Cancer research

authors

Mickisch GH,Licht T,Merlino GT,Gottesman MM,Pastan I

subject

Has Abstract

pub_date

1991-10-01 00:00:00

pages

5417-24

issue

19

eissn

0008-5472

issn

1538-7445

journal_volume

51

pub_type

杂志文章
  • In vivo administration of interferon alpha and interleukin 2 induces proliferation of lymphoid cells in the organs of mice.

    abstract::We have previously shown that interleukin 2 (IL-2) synergizes with interferon alpha (IFN-alpha) in mediating the regression of established pulmonary and hepatic metastases and the reduction of intradermal tumor in various murine tumor models. To understand the mechanism of synergy, we have examined lymphoid cell proli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Puri RK,Travis WD,Rosenberg SA

    更新日期:1990-09-01 00:00:00

  • Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate.

    abstract::The effect of "antiangiogenesis" therapy using cortisone acetate (CA) with or without heparin on tumor growth as well as in combination with chemotherapy was investigated. C3H mice were implanted intradermally with N-[4-(5-nitro-2-furyl)-thiazolyl]formamide induced undifferentiated transitional cell carcinoma, MBT-2, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lee K,Erturk E,Mayer R,Cockett AT

    更新日期:1987-10-01 00:00:00

  • Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography.

    abstract::To improve tumor:tissue ratios in immunoscintigraphy, a three-step targeting method has been developed. The reagents used were (a) a radioactive, low molecular weight chelate prepared from ionic gallium and a phenolic polyaminocarboxylic acid, which can be labeled either with the single-photon emitter 67Ga or with the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schuhmacher J,Klivényi G,Matys R,Stadler M,Regiert T,Hauser H,Doll J,Maier-Borst W,Zöller M

    更新日期:1995-01-01 00:00:00

  • Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.

    abstract::The von Hippel-Lindau (VHL) tumor suppressor gene is mutated in patients with VHL disease and in the majority of patients with sporadic clear cell renal carcinoma (RCC). Overexpression of transforming growth factor (TGF) beta1 has been observed in patients with several cancers, including RCCs, with serum and urine lev...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ananth S,Knebelmann B,Grüning W,Dhanabal M,Walz G,Stillman IE,Sukhatme VP

    更新日期:1999-05-01 00:00:00

  • Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines.

    abstract::The purpose of these studies was to examine the antiproliferative properties of 16 recombinant human IFN-alpha B/D hybrids against various human tumor lines of different histological origin and to determine whether any of the hybrid molecules possessed immunomodulating activity that could active antitumor properties i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fidler IJ,Heicappell R,Saiki I,Grutter MG,Horisberger MA,Nuesch J

    更新日期:1987-04-15 00:00:00

  • Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses.

    abstract::Expression of non-self antigens by tumors can induce activation of T cells in vivo, although this activation can lead to either immunity or tolerance. CD8+ T-cell activation can be direct (if the tumor expresses MHC class I molecules) or indirect (after the capture and cross-presentation of tumor antigens by dendritic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-3163

    authors: Zeelenberg IS,Ostrowski M,Krumeich S,Bobrie A,Jancic C,Boissonnas A,Delcayre A,Le Pecq JB,Combadière B,Amigorena S,Théry C

    更新日期:2008-02-15 00:00:00

  • Intracellular ATP levels determine cell death fate by apoptosis or necrosis.

    abstract::Although apoptosis and necrosis are morphologically distinct manifestations of cell death, apoptosis and some necroses share common features in the death signaling pathway involving functional steps of death-driving interleukin 1beta-converting enzyme family proteases and anti-cell death protein Bcl-2. One evident phy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eguchi Y,Shimizu S,Tsujimoto Y

    更新日期:1997-05-15 00:00:00

  • CMAP: a novel cystatin-like gene involved in liver metastasis.

    abstract::A novel metastasis-associated gene was identified with a differential display system in murine carcinoma cells showing a high rate of metastasis to the liver. A human homologue was also identified using a PCR-based strategy. The protein coded by this gene was named cystatin-like metastasis-associated protein (CMAP) an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Morita M,Yoshiuchi N,Arakawa H,Nishimura S

    更新日期:1999-01-01 00:00:00

  • Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.

    abstract::To understand the involvement of allelic losses and inactivation of tumor suppressor genes for the development of endometrial carcinoma of the uterus (EC), 24 cases of EC were examined for loss of heterozygosity (LOH) using a total of 57 polymorphic DNA markers covering all 23 pairs of chromosomes. LOH was observed at...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Okamoto A,Sameshima Y,Yamada Y,Teshima S,Terashima Y,Terada M,Yokota J

    更新日期:1991-10-15 00:00:00

  • Induction by some protein kinase inhibitors of differentiation of a mouse megakaryoblastic cell line established by coinfection with Abelson murine leukemia virus and recombinant SV40 retrovirus.

    abstract::Mouse C1 line cells are megakaryoblastic cells established by coinfection of Abelson murine leukemia virus and recombinant simian virus 40. We examined the effects of various compounds on growth and differentiation of these cells. Megakaryocytic differentiation of C1 cells was not induced by cytokines that stimulate m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Honma Y,Okabe-Kado J,Kasukabe T,Hozumi M,Kajigaya S,Suda T,Miura Y

    更新日期:1991-09-01 00:00:00

  • Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.

    abstract::Blood vessels deliver oxygen and nutrients to tissues, and vascular networks are spatially organized to meet the metabolic needs for maintaining homeostasis. In contrast, the vasculature of tumors is immature and leaky, resulting in insufficient delivery of nutrients and oxygen. Vasculogenic processes occur normally i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0412

    authors: Sasajima J,Mizukami Y,Sugiyama Y,Nakamura K,Kawamoto T,Koizumi K,Fujii R,Motomura W,Sato K,Suzuki Y,Tanno S,Fujiya M,Sasaki K,Shimizu N,Karasaki H,Kono T,Kawabe J,Ii M,Yoshiara H,Kamiyama N,Ashida T,Bardeesy N,

    更新日期:2010-08-01 00:00:00

  • LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.

    abstract::We recently reported that LY294002 (LY29) and LY303511 (LY30) sensitized tumor cells to drug-induced apoptosis independent of the phosphoinositide 3-kinase/Akt pathway. Here, we investigated the mechanism of LY30-induced sensitization of human neuroblastoma cells to TRAIL-mediated apoptosis. We provide evidence that L...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1996

    authors: Shenoy K,Wu Y,Pervaiz S

    更新日期:2009-03-01 00:00:00

  • High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation.

    abstract::A novel method for high-efficiency and region- controlled in vivo gene transfer was developed by combining in vivo electroporation and intraarterial plasmid DNA injection. A mammalian expression plasmid for the Escherichia coli lacZ gene (driven with a SV40 early promoter) was injected into the internal carotid artery...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nishi T,Yoshizato K,Yamashiro S,Takeshima H,Sato K,Hamada K,Kitamura I,Yoshimura T,Saya H,Kuratsu J,Ushio Y

    更新日期:1996-03-01 00:00:00

  • Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.

    abstract::Angiogenesis inhibitor TNP-470, 6-O-(N-chloroacetyl-carbamoyl)-fumagillol, semisynthetic analogue of fumagillin, has strong inhibitory activities against in vivo tumor growth and metastasis in a wide variety of tumors. However, it is still unknown whether this agent inhibits bone metastasis. We examined the effects of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sasaki A,Alcalde RE,Nishiyama A,Lim DD,Mese H,Akedo H,Matsumura T

    更新日期:1998-02-01 00:00:00

  • Inhibition of DNA excision repair by methotrexate in Chinese hamster ovary cells following exposure to ultraviolet irradiation or ethylmethanesulfonate.

    abstract::Previous results have suggested that methotrexate (MTX) could interfere with the repair of spontaneous DNA damage. To determine its effects on induced DNA damage, MTX was compared to hydroxyurea and arabinofuranosylcytosine (H/A), a drug combination known to block the DNA polymerase step of excision repair, for its ab...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Borchers AH,Kennedy KA,Straw JA

    更新日期:1990-03-15 00:00:00

  • Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.

    abstract::It had been shown previously that the ribonucleotide reductase from mouse tumor consisted of two nonidentical components (Tris and dye fractions, each prepared from the 20 to 40% (NH/)2SO4 protein fraction containing the ribonucleotide reductase activity by blue dextran-Sepharose chromatography). The individual compon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cory JG,Fleischer AE

    更新日期:1979-11-01 00:00:00

  • Potentiation of invasive capacity of rat ascites hepatoma cells by adriamycin.

    abstract::The effect of Adriamycin on the invasive capacity of rat ascites hepatoma cells, W1, was studied. The invasive capacity of W1 cells was estimated in vitro by counting the number of penetrated single tumor cells and tumor cell colonies formed from the penetrated cells underneath a cultured mesothelial cell monolayer (H...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Imamura F,Horai T,Mukai M,Shinkai K,Akedo H

    更新日期:1990-04-01 00:00:00

  • Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.

    abstract::Elevated levels of TGFβ are a negative prognostic indicator for patients diagnosed with pancreatic cancer; as a result, the TGFβ pathway is an attractive target for therapy. However, clinical application of pharmacologic inhibition of TGFβ remains challenging because TGFβ has tumor suppressor functions in many epithel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1807

    authors: Ostapoff KT,Cenik BK,Wang M,Ye R,Xu X,Nugent D,Hagopian MM,Topalovski M,Rivera LB,Carroll KD,Brekken RA

    更新日期:2014-09-15 00:00:00

  • Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth.

    abstract::mtCLIC/CLIC4 is a p53 and tumor necrosis factor alpha (TNFalpha) regulated intracellular chloride channel protein that localizes to cytoplasm and organelles and induces apoptosis when overexpressed in several cell types of mouse and human origin. CLIC4 is elevated during TNFalpha-induced apoptosis in human osteosarcom...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Suh KS,Mutoh M,Gerdes M,Crutchley JM,Mutoh T,Edwards LE,Dumont RA,Sodha P,Cheng C,Glick A,Yuspa SH

    更新日期:2005-01-15 00:00:00

  • Stimulation of the nuclear uracil DNA glycosylase in proliferating human fibroblasts.

    abstract::The cell cycle stimulation of individual species of the uracil DNA glycosylase was examined in WI-38 normal diploid fibroblasts. The nuclear uracil DNA glycosylase was induced as WI-38 cells traversed the cell cycle. In contrast, the specific activity of the mitochondrial glycosylase remained constant during cell prol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gupta PK,Sirover MA

    更新日期:1981-08-01 00:00:00

  • ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.

    abstract::Enhanced glucose and lipid metabolism is one of the most common properties of malignant cells. ATP citrate lyase (ACLY) is a key enzyme of de novo fatty acid synthesis responsible for generating cytosolic acetyl-CoA and oxaloacetate. To evaluate its role in lung cancer progression, we here analyzed ACLY expression in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1235

    authors: Migita T,Narita T,Nomura K,Miyagi E,Inazuka F,Matsuura M,Ushijima M,Mashima T,Seimiya H,Satoh Y,Okumura S,Nakagawa K,Ishikawa Y

    更新日期:2008-10-15 00:00:00

  • A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.

    abstract::Membrane-bound complement inhibitors protect host cells from inadvertent complement attack, and complement inhibitors are often up-regulated on tumors, possibly representing a selective adaptation by tumors to escape elimination by a host antitumor immune response. Relevant in vivo studies using rodent models of human...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Caragine TA,Okada N,Frey AB,Tomlinson S

    更新日期:2002-02-15 00:00:00

  • A Biophysical Model Uncovers the Size Distribution of Migrating Cell Clusters across Cancer Types.

    abstract::Migration from the primary tumor is a crucial step in the metastatic cascade. Cells with various degrees of adhesion and motility migrate and are launched into the bloodstream as single circulating tumor cells (CTC) or multicellular CTC clusters. The frequency and size distributions of these clusters have been recentl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1726

    authors: Bocci F,Kumar Jolly M,Onuchic JN

    更新日期:2019-11-01 00:00:00

  • Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasome, induces apoptosis in various tumor cells, but its mechanism of action is unclear. Treatment with PS-341 induces apoptosis in SUDHL6 (DHL6), but not SUDHL4 (DHL4), lymphoma cells. Microarray analysis shows high RNA levels of heat shock protein-27 (Hsp27) in DHL4...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chauhan D,Li G,Shringarpure R,Podar K,Ohtake Y,Hideshima T,Anderson KC

    更新日期:2003-10-01 00:00:00

  • Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.

    abstract::Focal adhesion kinase (FAK) and vascular endothelial growth factor receptor-3 (VEGFR-3) are protein tyrosine kinases that are overexpressed in human cancer and play an important role in survival signaling. In addition to its involvement with cell survival, VEGFR-3 is a primary factor in lymphatic angiogenesis. Because...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1661

    authors: Garces CA,Kurenova EV,Golubovskaya VM,Cance WG

    更新日期:2006-02-01 00:00:00

  • Role of amino acid depletion in combined treatment of neoplastic cells with methotrexate and L-asparaginase.

    abstract::The effect of pretreatment with L-asparaginase on the cytotoxicity of methotrexate (MTX) was studied in L5178Y murine leukemic cells and L-929 cells grown in vitro. The results were correlated with the effects of L-asparaginase on DNA synthesis. At low concentrations of the enzyme, pretreatment of cells enhanced the e...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chlopkiewicz B,Koziorowska J

    更新日期:1975-06-01 00:00:00

  • Deficiency in DNA polymerase beta provokes replication-dependent apoptosis via DNA breakage, Bcl-2 decline and caspase-3/9 activation.

    abstract::Cells deficient in DNA polymerase beta (beta-pol) are impaired in base excision repair (BER) and hypersensitive to various DNA damaging agents, including methylating mutagens. Hypersensitivity of beta-pol-deficient cells to methylating agents is because of induction of apoptosis (Ochs et al., Cancer Res., 59: 1544-155...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ochs K,Lips J,Profittlich S,Kaina B

    更新日期:2002-03-01 00:00:00

  • Combined integrin phosphoproteomic analyses and small interfering RNA--based functional screening identify key regulators for cancer cell adhesion and migration.

    abstract::Integrins interact with extracellular matrix (ECM) and deliver intracellular signaling for cell proliferation, survival, and motility. During tumor metastasis, integrin-mediated cell adhesion to and migration on the ECM proteins are required for cancer cell survival and adaptation to the new microenvironment. Using st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-2515

    authors: Chen Y,Lu B,Yang Q,Fearns C,Yates JR 3rd,Lee JD

    更新日期:2009-04-15 00:00:00

  • Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion.

    abstract::Topotecan, a water-soluble semisynthetic analogue of camptothecin, is the first topoisomerase I inhibitor to undergo evaluation in pediatric patients with refractory malignancies. A phase I and pharmacokinetic study was performed to determine the maximum tolerated dose (MTD) and dose-limiting toxicities, the incidence...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Blaney SM,Balis FM,Cole DE,Craig C,Reid JM,Ames MM,Krailo M,Reaman G,Hammond D,Poplack DG

    更新日期:1993-03-01 00:00:00

  • Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.

    abstract::In a preceding paper (D. B. Alexander et al., Cancer Res., 53: 1808-1815, 1993), we demonstrated that the in vitro glucocorticoid inhibition of Con8 mammary tumor cell growth is accompanied by the disruption of a transforming growth factor alpha (TGF-alpha) autocrine loop. This growth suppression response functions in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goya L,Alexander DB,Webster MK,Kern FG,Guzman RC,Nandi S,Firestone GL

    更新日期:1993-04-15 00:00:00